22-17108407-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014339.7(IL17RA):​c.1188G>A​(p.Leu396Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0281 in 1,614,048 control chromosomes in the GnomAD database, including 4,307 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 405 hom., cov: 34)
Exomes 𝑓: 0.028 ( 3902 hom. )

Consequence

IL17RA
NM_014339.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.36

Publications

22 publications found
Variant links:
Genes affected
IL17RA (HGNC:5985): (interleukin 17 receptor A) Interleukin 17A (IL17A) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. The transmembrane protein encoded by this gene (interleukin 17A receptor; IL17RA) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2014]
IL17RA Gene-Disease associations (from GenCC):
  • immunodeficiency 51
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 22-17108407-G-A is Benign according to our data. Variant chr22-17108407-G-A is described in ClinVar as Benign. ClinVar VariationId is 340594.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.289 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RANM_014339.7 linkc.1188G>A p.Leu396Leu synonymous_variant Exon 13 of 13 ENST00000319363.11 NP_055154.3 Q96F46-1
IL17RANM_001289905.2 linkc.1086G>A p.Leu362Leu synonymous_variant Exon 12 of 12 NP_001276834.1 Q96F46-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RAENST00000319363.11 linkc.1188G>A p.Leu396Leu synonymous_variant Exon 13 of 13 1 NM_014339.7 ENSP00000320936.6 Q96F46-1
IL17RAENST00000612619.2 linkc.1086G>A p.Leu362Leu synonymous_variant Exon 12 of 12 5 ENSP00000479970.1 Q96F46-2

Frequencies

GnomAD3 genomes
AF:
0.0295
AC:
4492
AN:
152196
Hom.:
406
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00449
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0784
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.0389
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00454
Gnomad OTH
AF:
0.0315
GnomAD2 exomes
AF:
0.0757
AC:
19011
AN:
251140
AF XY:
0.0722
show subpopulations
Gnomad AFR exome
AF:
0.00511
Gnomad AMR exome
AF:
0.197
Gnomad ASJ exome
AF:
0.0162
Gnomad EAS exome
AF:
0.313
Gnomad FIN exome
AF:
0.0396
Gnomad NFE exome
AF:
0.00549
Gnomad OTH exome
AF:
0.0545
GnomAD4 exome
AF:
0.0279
AC:
40839
AN:
1461734
Hom.:
3902
Cov.:
62
AF XY:
0.0304
AC XY:
22117
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.00299
AC:
100
AN:
33478
American (AMR)
AF:
0.183
AC:
8199
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0157
AC:
409
AN:
26132
East Asian (EAS)
AF:
0.290
AC:
11526
AN:
39698
South Asian (SAS)
AF:
0.139
AC:
11991
AN:
86256
European-Finnish (FIN)
AF:
0.0412
AC:
2194
AN:
53306
Middle Eastern (MID)
AF:
0.00798
AC:
46
AN:
5768
European-Non Finnish (NFE)
AF:
0.00354
AC:
3936
AN:
1111984
Other (OTH)
AF:
0.0404
AC:
2438
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2416
4832
7248
9664
12080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
536
1072
1608
2144
2680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0296
AC:
4501
AN:
152314
Hom.:
405
Cov.:
34
AF XY:
0.0350
AC XY:
2604
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00447
AC:
186
AN:
41584
American (AMR)
AF:
0.0785
AC:
1201
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
52
AN:
3470
East Asian (EAS)
AF:
0.301
AC:
1558
AN:
5170
South Asian (SAS)
AF:
0.146
AC:
707
AN:
4826
European-Finnish (FIN)
AF:
0.0389
AC:
413
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00454
AC:
309
AN:
68030
Other (OTH)
AF:
0.0345
AC:
73
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
198
396
593
791
989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0211
Hom.:
167
Bravo
AF:
0.0342
Asia WGS
AF:
0.209
AC:
727
AN:
3478
EpiCase
AF:
0.00333
EpiControl
AF:
0.00350

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial Candidiasis, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunodeficiency 51 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.27
DANN
Benign
0.79
PhyloP100
-2.4
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229151; hg19: chr22-17589297; COSMIC: COSV60053540; API